Head and Neck Cancer

References

• Janjan N., Campbell B., Wilson J., Toohill R. Radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: a review of recent techniques. Cancer Treat Rev 1990; 17: 89–101, (L1)
   PubMed Web of Science ®Google Scholar
• Vokes E., Weichselbaum R., Lippman S., Hong W. Head and neck cancer. N Engl J Med 1993; 328: 184–94, (L1)
   PubMed Web of Science ®Google Scholar
• Russel N., Bartelink H. Optimized radiotherapy for head and neck cancer. Curr Opin Oncol 1992; 4: 491–8, (L1)
   PubMedGoogle Scholar
• Vokes E., Awan A., Weichselbaum R. Radiotherapy with concomitant chemotherapy for head and neck cancer. Hematol Oncol Clin North Am 1991; 5: 753–67, (L1)
   PubMed Web of Science ®Google Scholar
• Hamasaki V., Vokes E. Chemotherapy in head and neck cancer. Curr Opin Oncol 1992; 4: 504–11, (L1)
   PubMedGoogle Scholar
• Bataini J., Jaulerry C., Brunin F., Ponvert D., Ghossein N. Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx. Head Neck 1990; 12: 41–9, (R1/1897)
   PubMed Web of Science ®Google Scholar
• Leibel S., Scott C., Mohiuddin M., Marcial V., Coia L., Davis L., Fuks Z. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991; 21: 549–56, (R1/2648)
   PubMed Web of Science ®Google Scholar
• Tubiana M. The role of local treatment in the cure of cancer. Eur J Cancer 1992; 28A: 2061–9, (L1)
   PubMed Web of Science ®Google Scholar
• Maher E. J., Jefferis A. F. Decision making in advanced cancer of the head and neck: variation in the views of medical specialists. J Royal Soc Med 1990; 83: 356–9, (O2)
   PubMed Web of Science ®Google Scholar
• Cachin Y., Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev 1975; 2: 177–91, (L2)
   PubMed Web of Science ®Google Scholar
• Fletcher G. H., Jessee R. H. The place of irradiation in the management of the primary lesion in head and neck cancers. Cancer 1977; 39: 862–7, (L2)
   PubMed Web of Science ®Google Scholar
• Fletcher G. Oral cavity and oropharynx. Textbook of Radiotherapy, 3rd ed. Lean and Febiger, Philadelphia 1980; 286–329, (L1)
   Google Scholar
• Pierquin B., Wilson J. F., Chassagne D. Modern brachytherapy. Masson, New York 1987; 87–168, (L2)
   Google Scholar
• McCaffrey T. Head and neck cancer surgery. Curr Opin Oncol 1992; 4: 499–503, (L1)
   PubMedGoogle Scholar
• Finlay P. M., Dawson F., Robertson A. G., Soutar D. S. An evaluation of functional outcome after surgery and radiotherapy for intraoral cancer. Brit J Oral Maxillofac Surg 1992; 30: 14–17, (P1/255)
   PubMed Web of Science ®Google Scholar
• Ridge J. Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence. Sem Oncol 1993; 20: 419–29, (L1)
   PubMed Web of Science ®Google Scholar
• Keidan R. D., Kusiak J. F. Complications following reconstruction with the pectoralis major myocutaneous flap: The effect of prior radiation therapy. Laryngoscope 1992; 102: 521–4, (R3/40)
   PubMed Web of Science ®Google Scholar
• Marcial V., Pajak T., Kramer S., Davis L., Stetz J., Laramore G., Jacobs J., A1-Sarraf M., Brady L. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer. Semin Oncol 1988; 15: 39–60, (O2)
   PubMed Web of Science ®Google Scholar
• Dische S. Radiotherapy in the nineties. Increase in cure decrease in morbidity. Acta Oncol 1992; 31: 501–11, (O1)
   PubMed Web of Science ®Google Scholar
• Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29: 1446–9, (R1/2044)
   PubMed Web of Science ®Google Scholar
• Bataini J. P., Bernier J., Brugere J., Jaulerry C., Picco C., Brunin F. Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx. Radio-ther Oncol 1985; 3: 245–55, (R1/1666)
   PubMed Web of Science ®Google Scholar
• Snow G. B., Balm A. J. M., Arendse J. W., . Prognostic factors in neck node metastasis. Cancer in the neck. Evaluation and treatment, D. L. Larson, et al. MacMillan., New York 1986; 53–63, (R2/736)
   Google Scholar
• Ghouri A. F., Zamora R. L., Harvey J. E., Spitznagel E. L., Sessions D. G. Epidermoid carcinoma of the oral cavity and oropharynx: Validity of the current AJCC staging system and new statistical tools for the prediction of subclinical neck disease. Otolaryngol Head Neck Surg 1993; 108: 225–32, (R1/531)
   PubMed Web of Science ®Google Scholar
• Marks J. E., Devineni V. R., Harvey J., Sessions D. G. The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol 1992; 13: 34–9, (R1/846)
   PubMed Web of Science ®Google Scholar
• Fletcher G. H. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer 1972; 29: 1450–4, (L1)
   PubMed Web of Science ®Google Scholar
• Bataini J., Bernier J., Jaulerry C., Brunin F., Pontvert D. Impact of cervical disease and its definitive radiotherapeutic management on survival: experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx. Laryngoscope 1990; 100: 716–23, (R1/2013)
   PubMed Web of Science ®Google Scholar
• Vandenbrouck C., Sancho-Garnier H., Chassagne D., Saravane D., Cachin Y., Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity. Cancer 1980; 46: 386–90, (C2/75)
   PubMed Web of Science ®Google Scholar
• Suárez C., Llorente J. L., Nuñez F., Diaz C., Gomez J. Neck dissection with or without postoperative radiotherapy in supraglottic carcinomas. Otolaryngol Head Neck Surg 1993; 109: 3–9, (R2/302)
   PubMed Web of Science ®Google Scholar
• Varghese C., Sankaranarayanan R., Nair B., Nair M. Predictors of neck node control in radically irradiated squamous cell carcinoma of the oropharynx and laryngopharynx. Head Neck 1993; 15: 105–8, (R2/171)
   PubMed Web of Science ®Google Scholar
• Peters L. J., Goepfert H., Ang K. K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993; 26: 3–11, (C2/240)
   PubMed Web of Science ®Google Scholar
• Mancuso A. Cervical lymph node metastases: Oncological imaging and diagnosis. Int J Radiat Oncol Biol Phys 1984; 10: 411–3, (O1)
   PubMed Web of Science ®Google Scholar
• Korb L., Spaulding C., Constable W. The role of definitive radiation therapy in squamous cell carcinoma of the oral tongue. Cancer 1991; 67: 2733–7, (R2/114)
   PubMed Web of Science ®Google Scholar
• Mendenhall W., Million R., Cassisi N. Elective neck irradiation in squamous cell carcinoma of the head and neck. Head Neck Surg 1980; 3: 15–20, (R1/159)
   PubMedGoogle Scholar
• Pukander J., Karhuketo T., Penttila M., Pertovaara H., Karma P. Radical surgery for lingual cancer. Clin Otolaryngol 1990; 15: 229–34, (R2/58)
   PubMed Web of Science ®Google Scholar
• Dearnaley D., Dardoufas C.A', Hearn R., Henk J. Interstitial irradiation for carcinoma of the tongue and floor of mouth: Royal Marsden Hospital Experience 1970–1986. Radiother Oncol 1991; 21: 183–92, (R1/149)
   PubMed Web of Science ®Google Scholar
• Benk V., Mazeron J., Grimard L., et al. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol 1990; 18: 339–47, (R2/110)
   PubMed Web of Science ®Google Scholar
• Lefebvre J., Coche-Dequeant B., Castelain B., Prevost B., Buisset E., Van Ton J. Interstitial brachytherapy and early tongue squamous cell carcinoma management. Head Neck 1990; 12: 232–6, (R2/341)
   PubMed Web of Science ®Google Scholar
• Mazeron J., Crook J., Benck V., et al. Iridium 192 implantation of Tl and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990; 19: 1369–76, (R2/166)
   PubMed Web of Science ®Google Scholar
• Montemaggi P., Smaniotto D., Morganti A., Luzi S. Combined external beam irradiation and interstitial radiotherapy of T1-T2 cancers of the mobile tongue and floor of mouth. Rays 1991; 16: 53–8, (R3/31)
   PubMedGoogle Scholar
• Bachaud J., Delannes M. M., Allouache N., et al. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth. Radiother Oncol 1994; 31: 199–206, (R2/94)
   PubMed Web of Science ®Google Scholar
• Schmidt-Ullrich R., Zwicker R., Wu A., Kelly K. Interstitial IR-192 implants of the oral cavity: the planning and construction of volume implants. Int J Radiat Oncol Biol Phys 1991; 20: 1079–85, (O1)
   PubMed Web of Science ®Google Scholar
• Henk J. M. Treatment of oral cancer by interstitial irradiation using iridium-192. Br J Oral Maxillofac Surg 1992; 30: 355–9, (R2/67)
   PubMed Web of Science ®Google Scholar
• Wang C. Radiotherapeutic management and results of T1N0 T2N0 carcinoma of the oral tongue: evaluation of boost techniques. Int J Radiat Oncol Biol Phys 1989; 17: 287–91, (R2/142)
   PubMed Web of Science ®Google Scholar
• Hanks G., Kramer S., Diamond J., Herring D. Patterns of care outcome survey: national outcome data for six disease sites. Am J Clin Oncol 1982; 5: 349–53, (R1/669)
   PubMed Web of Science ®Google Scholar
• Padmanabhan T., Sankaranarayanan R., Krishnan Nair M. Evaluation of local control survival and pattern of failure with radiotherapy in cancer of the tongue. Oncology 1990; 47: 121–3, (R2/105)
   PubMed Web of Science ®Google Scholar
• Leung T-W., Lee A. W. M., Chan D. K. K. Definitive radiotherapy for carcinoma of the oral tongue. Acta Oncol 1993; 32: 559–64, (R2/125)
   PubMed Web of Science ®Google Scholar
• Shibuya H., Hoshina M., Takeda M., Matsumoto S., Suzuki S., Okada N. Brachytherapy for stage I & II oral tongue cancer: An analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys 1993; 26: 51–8, (R1/370)
   PubMed Web of Science ®Google Scholar
• Million R., Cassisi N., Clark J. Cancer of the head and neck. Principles and Practice of Oncology, Cancer.3rd, V. T. DeVita, S. Hellman, S. A. Rosenberg. Lippincott, Philadelphia 1989; 488–590, (L1)
   Google Scholar
• Lambin P., Haie-Meder C., Gerbaulet A., Chassagne D. Curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinoma of the mobile tongue. Radiother Oncol 1992; 23: 55–6, (O3)
   PubMed Web of Science ®Google Scholar
• Pernot M., Malissard L., Aletti P., Hoffstetter S., Forcard J. J., Bey P. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol 1992; 23: 223–8, (R2/147)
   PubMed Web of Science ®Google Scholar
• Bundgaard T., Tandrup O Elbrønd O. A functional evaluation of patients treated for oral cancer. A prospective study. Int J Oral Maxillofac Surg 1993; 22: 28–34, (P1/87)
   PubMed Web of Science ®Google Scholar
• Wendt C., Peters L., Delclos L., Ang K., Morrison W., Maor M., Robbins K., Byers R., Carlson L., Oswald M. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy: see comments. Int J Radiat Oncol Biol Phys 1990; 18: 1287–92, (R2/103)
   PubMed Web of Science ®Google Scholar
• Riessbeck K., Müller A., Rink B., Dalluge K., Below M. Die Ergebnisse der präoperativen Strahlentherapie des fortgeschrittenen Mundboden-Zungenkarzinomas. Radiobiol Radiother (Berlin) 1989; 30: 373–5, (C3/120)
   PubMedGoogle Scholar
• Rink B., Neumann H., Kuchler I. Klinische Erfahrungen mit underschiedlichen Vorbestrahlungsmodi bei fortgeschrittenen Zungen-Mundbodenkarzinomen. Dtsch Z Mund Kiefer Gesichtschir 1989; 13: 286–90, (C2/90)
   PubMedGoogle Scholar
• Mendenhall W., Parsons J., Stringer S., Cassisi N., Million R. T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications. Radiother Oncol 1989; 16: 275–81, (R3/42)
   PubMed Web of Science ®Google Scholar
• Zelefsky M., Harrison L., Fass D., Armstrong J., Spiro R., Shah J., Strong E. Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome. Head Neck 1990; 12: 470–5, (R1/51)
   PubMed Web of Science ®Google Scholar
• Dandapat M. C., Mukherjee L. M., Mishra S. B., Kar N. K. Management of oral cancer in late stages: A review. J Indian Med Assoc 1992; 90: 153–5, (R3/60)
   PubMedGoogle Scholar
• Wazer D., Schmidt-Ulrich R., Keisch M., Karmody C., Koch W. The role of combined composite resection and irradiation in the management of carcinoma of the oral cavity and oropharynx. Strahlenther Onkol 1989; 165: 18–22, (R3/35)
   PubMed Web of Science ®Google Scholar
• Hall E. J., Brenner D. J. The dose-rate effect in interstitial brachytherapy: a controversy resolved. Br J Radiol 1992; 65: 242–7, (O2)
   PubMed Web of Science ®Google Scholar
• Mahe M., De Laroche G., Romestaing P., Marquis I, Mont-Barbon X, Ardiet J. M., Sentenac I., Gerard J. P. An original technique of brachytherapy for T1 T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1993; 25: 513–6, (P2/24)
   PubMed Web of Science ®Google Scholar
• Simon J. M., Mazeron J. J., Pohar S., et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 1993; 26: 19–25, (R2/274)
   PubMed Web of Science ®Google Scholar
• Spaulding C., Korb L., Constable W., Cantrell R., Levine P. The influence of extent of neck treatment upon control of cervical lymphadenopathy in cancers of the oral tongue. Int J Radiat Oncol Biol Phys 1991; 21: 577–81, (R2/84)
   PubMed Web of Science ®Google Scholar
• Hemprich A., Müller R. Long-term results in treating squamous cell carcinoma of the lip, oral cavity, and oropharynx. Int J Oral Maxillofac Surg 1989; 18: 39–42, (R2/352)
   PubMed Web of Science ®Google Scholar
• Fietkau R., Grabenbauer G., Iro H., Müller R., Farmand M., Atendorf-Hofmann A., Sauer R. Interstitiella und perkutane Strahlentherapie nach begrenzten chirurgischen Eingriffen beim Mundhohlenkarzinom. Strahlenther Onkol 1991; 167: 591–8, (L2)
   PubMedGoogle Scholar
• Horiuchi J., Takeda M., Shibuya H., Matsumoto S., Hoshina M., Suzuki S. Usefulness of198Au grain implants in the treatment of oral and oropharyngeal cancer. Radiother Oncol 1991; 21: 29–38, (R2/177)
   PubMed Web of Science ®Google Scholar
• Mazeron J., Simon J., Le Pechoux C., Crook J., Grimard L., Piedbois P., Le Bourgeois J., Pierquin B. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol 1991; 21: 39–47, (R1/279)
   PubMed Web of Science ®Google Scholar
• Perez C., Brady L. Principles and practice of radiation oncology.2nd ed. JB Lippincott Co, Philadelphia 1992, (L1)
   Google Scholar
• Jones A. S., Khan H. The patterns and treatment of recurrence following radiotherapy for carcinoma of the oral cavity. Clin Otolaryngol 1993; 18: 14–18, (R2/186)
   PubMed Web of Science ®Google Scholar
• Teshima T., Inoue T., Chatani M., Hata K., Hiyama T., Ikeda H., Murayama S. Incidence of other primary cancers in 1569 patients with pharyngolaryngeal cancer and treated with radiation therapy. Strahlenther Onkol 1992; 168: 213–8, (R2/1569)
   PubMedGoogle Scholar
• Fijuth J., Mazeron J-J, Le Péchoux C., et al. Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 1992; 24: 59–64, (R1/600)
   PubMed Web of Science ®Google Scholar
• Jaulerry C., Rodriques J., Brunin F., et al. Results of radiation therapy in carcinoma of the base of the tongue. The Curie Institute experience with about 166 cases. Cancer 1991; 67: 1532–8, (R1/166)
   PubMed Web of Science ®Google Scholar
• Logemann J. A., Pauloski B. R., Rademaker A. W., et al. Speech and swallow function after tonsil/base of tongue resection with primary closure. J Speech Hearing Res 1993; 36: 918–26, (P2/11)
   PubMedGoogle Scholar
• Ausili-Cefaro G., Nardone L., Salvi G., Marmiroli L. Indications and results of combined external beam radiation and interstitial radiotherapy in the treatment of carcinoma of the oropharynx. Rays 1991; 16: 97–106, (L1)
   PubMedGoogle Scholar
• Calais G., Reynaud-Bougnoux A., Bougnoux P., Le Floch O. Squamous cell carcinoma of the base of the tongue: results of treatment in 115 cases. Br J Radiol 1989; 62: 849–53, (R2/115)
   PubMed Web of Science ®Google Scholar
• Lusinchi A., Eskandari J., Son Y., et al. External irradiation plus curietherapy boost in 108 base of tongue carcinomas. Int J Radiat Oncol Biol Phys 1989; 17: 1191–7, (R2/108)
   PubMed Web of Science ®Google Scholar
• Mazeron J., Crook J., Martin M., Peynegre R., Pierquin B. Iridium 192 implantation of squamous cell carcinomas of the oropharynx. Am J Otolaryngol 1989; 10: 317–21, (R2/127)
   PubMed Web of Science ®Google Scholar
• Mazeron J-J, Belkacemi Y., Simon J-M, et al. Place of iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int J Radiat Oncol Biol Phys 1993; 27: 251–7, (R2/165)
   PubMed Web of Science ®Google Scholar
• Sessions R., Harrison L., Strong E., Spiro R. A management plan for tongue base cancer that includes brachytherapy. Otolaryngol Head Neck Surg 1990; 103: 599–604, (O2)
   PubMed Web of Science ®Google Scholar
• Foote R., Parsons J., Mendenhall W., Million R., Cassisi N., Stringer S. Is interstitial implantation essential for successful radiotherapeutic treatment of base of tongue carcinoma. Int J Radiat Oncol Biol Phys 1990; 18: 1293–8, (R2/84)
   PubMed Web of Science ®Google Scholar
• Harrison L., Sessions R., Strong E., Fass D., Nori D., Fukz Z. Brachytherapy as part of the definitive management of squamous cancer of the base of tongue. Int J Radiat Oncol Biol Phys 1989; 17: 1309–12, (R3/17)
   PubMed Web of Science ®Google Scholar
• Harrison L. B., Zelefsky M. J., Sessions R. B., et al. Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: Oncologic and functional outcome. Radiol 1992; 184: 267–70, (R3/36)
   PubMed Web of Science ®Google Scholar
• Mendenhall W., Parsons J., Mendenhall N., Million R. Brachytherapy in head and neck cancer: selection criteria and results at the University of Florida. Oncology (Williston Park) 1991; 5: 44–54, 59–60. (L2)
   PubMedGoogle Scholar
• Marcial V., Hanley J., Hendrickson F., Ortiz H. Split-course radiation therapy of carcinoma of the base of the tongue: results of a prospective national collaborative clinical trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1983; 9: 437–43, (R2/141)
   PubMed Web of Science ®Google Scholar
• Tiwari R., Karim ABMF, Greven A. J., Snow G. B. Total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg 1993; 119: 945–9, (R3/26)
   PubMedGoogle Scholar
• Housset M., Baillet F., Delanian S., et al. Split course interstitial brachytherapy with a source shift: the results of a new iridium implant technique versus single course implants for salvage irradiation of base of tongue cancers in 55 patients. Int J Radiat Oncol Biol Phys 1991; 20: 965–71, (R2/55)
   PubMed Web of Science ®Google Scholar
• Kob D., Quade R., Gramowski K. Zum Stellenwerl der Strahlentherapie bei Pharynxkarzinomen. Radiobiol Radiother (Berl) 1989; 30: 331–7, (L2)
   PubMedGoogle Scholar
• Pernot M., Baillet F. Tonsillar region, B. Pierquin, J. F. Wilson, D. Chassagne. Modern brachytherapy. Masson., New York 1987; 5–141, (L2)
   Google Scholar
• Singh A. M., Bahadur S., Tandon D. A., Pande R. M. Anterior mandibulotomy for oral and oropharyngeal tumours. J Laryngol Otol 1993; 107: 316–9, (R3/39)
   PubMed Web of Science ®Google Scholar
• Lee W. R., Mendenhall W. M., Parsons J. T., Million R. R., Cassisi N. J., Stringer S. P. Carcinoma of the tonsillar region: A multivariate analysis of 243 patients treated with radical radiotherapy. Head Neck 1993; 15: 283–8, (R2/243)
   PubMed Web of Science ®Google Scholar
• Calais G., Chauvet B., Garand G, Beutter P., Reynaud-Bougnoux A., Le Floch O. Cancers de la region amygdalienne. Place de l'irradiation dans le traitement. Ann Radiol (Parisl 1989; 32: 555–9, (R2/137)
   PubMed Web of Science ®Google Scholar
• Calais G., Goga D., Garand G., Beutter P., Lo Floch O. Radiotherapie des carcinomes de l'oropharynx. Resultats de 10 ans d'experience au CHU de Tours. Rev Stomatol Chir Maxillofac 1989; 90: 24–9, (R2/305)
   PubMedGoogle Scholar
• Lusinchi A., Wibault P., Marandas P., Kunkler I., Eschwege F. Exclusive radiation therapy: the treatment of early tonsillar tumors. Int J Radiat Oncol Biol Phys 1989; 17: 273–7, (R2/93)
   PubMed Web of Science ®Google Scholar
• Wong C., Ang K., Fletcher G., et al. Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys 1989; 16: 657–62, (R2/150)
   PubMed Web of Science ®Google Scholar
• Di Marco A., Rizzotti A., Grandinetti A., Campostrini F., Palazzi M., Garusi G. External radiotherapy in the treatment of tonsillar carcinomas. Analysis of 183 cases. Tumori 1990; 76: 244–9, (R2/183)
   PubMed Web of Science ®Google Scholar
• Gehanno P., Depondt J., Guedon C., Kebaili C., Koka V. Primary and salvage surgery for cancer of the tonsillar region: A retrospective study of 120 patients. Head Neck 1993; 15: 185–9, (R2/120)
   PubMed Web of Science ®Google Scholar
• Kajanti M., Mantyla M. Squamous cell carcinoma of the tonsillar region. A retrospective analysis of treatment results. Acta Oncol 1991; 30: 629–33, (R3/75)
   PubMed Web of Science ®Google Scholar
• Perez C., Carmichael T., Devineni V., et al. Carcinoma of the tonsillar fossa: a nonrandomized comparison of irradiation alone or combined with surgery: long-term results. Head Neck 1991; 13: 282–90, (R2/296)
   PubMed Web of Science ®Google Scholar
• Lindelöv B., Monberg J., Hansen H. S. Squamous cell carcinoma of the oropharynx. Results of primary radiotherapy. Acta Oncol 1992; 31: 341–5, (R2/226)
   PubMed Web of Science ®Google Scholar
• Pernot M., Malissard L., Taghian A., Hoffstetter S., Luporsi E., Forçard J-J., Aletti P., Bey P. Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy results according to extension, localization, and dose rate. Int J Radiat Oncol Biol Phys 1992; 23: 715–23, (R2/277)
   PubMed Web of Science ®Google Scholar
• Kajanti M. J., Holsti L. R., Mäntylä MM. Postoperative radiotherapy of squamous cell carcinoma of the tonsil. Acta Oncol 1992; 31: 49–52, (R3/40)
   PubMed Web of Science ®Google Scholar
• O'Brien C. J., Castle G. K., Stevens G.N., Mac Halliday G., Donovan J. K., Lee K. K., Packham N. A., Peat M. J. Limitations of radiotherapy in the definitive treatment of squamous carcinoma of the tonsillar fossa. Aust NZJ Surg 1992; 62: 709–13, (R2/104)
   PubMedGoogle Scholar
• Thompson W. M., Foote R. L., Olsen K. D., Schaid D. J., Grado G. L., Buskirk S. J., Earle J. D. Postoperative irradiation for tonsillar carcinoma. Mayo Clin Proc 1993; 68: 665–9, (R3/16)
   PubMed Web of Science ®Google Scholar
• Zelefsky M. J. Harrison L. B. Armstrong J. G. Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer 1992; 70: 2388–95, (R2/51)
   Google Scholar
• Kramer S., Gelber R., Snow J, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer. Final report of study 73–03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987; 10: 19–30, (C2/277)
   PubMedGoogle Scholar
• Inoue T., Inoue T., Ikeda H., Teshima T., Murayama S., Yamazaki H., Otani M. Prognostic factor of radiotherapy for squamous cell carcinoma of oropharynx without clinically positive nodes. Strahlenther Onkol 1993; 169: 476–80, (R3/138)
   PubMedGoogle Scholar
• Tiedemann R. Behandlungsresultate bei Plattenepithelkarzinomen der Mundhöhle und des Oropharynx. Auris Nasus Larynx 1989; 16: 111–8, (R3/150)
   Google Scholar
• Pinsolle J., Demeaux H., Coustal B., Siberchicot F., Caudry M., Maire J-P, Michelet F-X. Results of surgical treatment of T3 and T4 tumors of the oral cavity and oropharynx. Am J Surg 1992; 164: 587–91, (R2/199)
   PubMed Web of Science ®Google Scholar
• Johansen L., Overgaard J., Overgaard M., Birkler N., Fisker A. Squamous cell carcinoma of the oropharynx: an analysis of 213 consecutive patients scheduled for primary radiotherapy. Laryngoscope 1990; 100: 985–90, (R2/213)
   PubMed Web of Science ®Google Scholar
• Zelefsky M. J., Harrison L. B., Fass D. E., Armstrong J. G., Shah J. P., Strong E. W. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 1992; 25: 17–21, (R2/102)
   Web of Science ®Google Scholar
• Bataini J., Asselain B., Jaulerry C., et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors. Radio-ther Oncol 1989; 14: 265–77, (R1/465)
   PubMed Web of Science ®Google Scholar
• Fowler J. F., Tanner M. A., Bataini J. P., Asselain B., Bernier J., Lave C. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 1990; 19: 237–44, (O2)
   PubMed Web of Science ®Google Scholar
• Marcial V. A., Pajak T. F., Rotman M., Brady L. W., Amato D. “Compensated” split-course versus continuous radiation therapy of carcinoma of the tonsillar fossa. Am J Clin Oncol 1993; 16: 389–96, (C2/137)
   PubMed Web of Science ®Google Scholar
• Meyza J., Towpik E. Surgical and cryosurgical salvage of oral and oropharyngeal cancer recurring after radical radiotherapy. Eur J Surg Oncol 1991; 17: 567–70, (R2/62)
   PubMed Web of Science ®Google Scholar
• Viani L., Dammeijer P., Jones A., Dalby J., Stell P. Recurrence of oropharyngeal carcinoma after radiotherapy. J Laryngol Otol 1991; 105: 24–8, (R2/221)
   PubMed Web of Science ®Google Scholar
• Kaasa S., Kragh-Jensen E., Bjordal K., et al. Prognostic factors in patients with nasopharyngeal carcinoma. Acta Oncol 1993; 32: 531–6, (R2/122)
   PubMed Web of Science ®Google Scholar
• Sham J., Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 1991; 13: 298–310, (R1/262)
   PubMed Web of Science ®Google Scholar
• Liu T. Recent developments in diagnosis and treatment of nasopharyngeal carcinoma. Keio J Med 1991; 40: 59–62, (L2)
   PubMedGoogle Scholar
• Leung S., Tsao S., Teo P., Foo W. Cranial nerve involvement by nasopharyngeal carcinoma: Response to treatment and clinical significance. Clin Oncol 1990; 2: 138–41, (R2/66)
   Google Scholar
• Reinfuss M., Skoyszewski J., Radkowski A. Poorly differentiated naso- and oropharyngeal carcinoma. A retrospective comparison between the results of radiotherapy alone and radiotherapy plus adjuvant methotrexate. Acta Oncol 1991; 30: 39–43, (R2/141)
   PubMed Web of Science ®Google Scholar
• Roth S., Sack H., Bertram G. Strahlentherapeutische Technik und Ergebnisse beim Nasopharyngxkarzinom an den Kölner Universitätskliniken von 1974 bis 1985. Strahlenther Onkol 1989; 165: 633–40, (R2/76)
   PubMed Web of Science ®Google Scholar
• Kajanti M., Mantyla M. Carcinoma of the nasopharynx. A retrospective analysis of treatment results in 125 patients. Acta Oncol 1990; 29: 611–4, (R2/125)
   PubMed Web of Science ®Google Scholar
• Ingersoll L., Woo S., Donaldson S., et al. Nasopharyngeal carcinoma in the young: a combined MD Anderson and Stanford experience. Int J Radiat Oncol Biol Phys 1990; 19: 881–7, (R2/57)
   PubMed Web of Science ®Google Scholar
• Perez C., Devineni V., Marcial-Vega V., Marks J., Simpson J., Kucik N. Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271–80, (R1/143)
   PubMed Web of Science ®Google Scholar
• Lee A. W. M., Law S. C. K., Foo W., et al. Nasopharyngeal carcinoma: local control by megavoltage irradiation. Br J Radiol 1993; 66: 528–36, (R1/4128)
   PubMed Web of Science ®Google Scholar
• Belgadi B., Richaud P., Lagarde P., et al. Radiotherapie descarcinomes du nasopharynx. Ann Otolaryngol Chir Cervicofac 1990; 107: 53–8, (R3/58)
   PubMedGoogle Scholar
• Itami J., Anzai Y., Nemoto K., et al. Prognostic factors for local control in nasopharyngeal cancer (NPC): analysis by multivariate proportional hazard models. Radiother Oncol 1991; 21: 233–9, (R2/67)
   PubMed Web of Science ®Google Scholar
• Meyer P., Methlin G., Untereiner M. Resultats therapeutiques d'une série de 73 cas de carcinome naso-pharynge. Ann Otho-Laryng 1989; 106: 567–76, (R2/73)
   PubMedGoogle Scholar
• Di Marco A., Pradella R., Campostrini F. Definitive irradiation of nasopharyngeal carcinoma: analysis of results and failures in 103 cases. Tumori 1991; 77: 343–9, (R2/103)
   PubMed Web of Science ®Google Scholar
• Bailet J. W., Mark R. J., Abemayor E., et al. Nasopharyngeal carcinoma: Treatment results with primary radiation therapy. Laryngoscope 1992; 102: 965–72, (R2/103)
   PubMed Web of Science ®Google Scholar
• Chatani M., Matayoshi Y., Masaki N., et al. Radiation therapy of the nasopharyngeal carcinoma. Strahlenther Onkol 1993; 169: 527–33, (R2/89)
   PubMedGoogle Scholar
• Chen W-Z, Zhou D-L, Luo K-SL. Long term observation after radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 311–4, (R2/323)
   PubMed Web of Science ®Google Scholar
• Sham J., Choy D. Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients. Br J Radiol 1990; 63: 51–8, (R1/759)
   PubMed Web of Science ®Google Scholar
• Chen C., Liu T., Zhao S. 10-year survival rate for patient with nasopharyngeal carcinoma after radiation therapy. Clinical analysis of 367 cases. Chin Med J 1989; 102: 239–42, (R3/367)
   PubMed Web of Science ®Google Scholar
• Lee A., Sham J., Poon Y., Ho J. Treatment of stage 1 nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation. Int J Radiat Oncol Biol Phys 1989; 17: 1183–90, (R1/196)
   PubMed Web of Science ®Google Scholar
• Lee A., Poon Y., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992; 23: 261–70, (R1/5037)
   PubMed Web of Science ®Google Scholar
• Johansen L. V., Mestre M., Overgaard J. Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck 1992; 14: 200–7, (R2/167)
   PubMed Web of Science ®Google Scholar
• Teo P., Tsao S., Shiu W., et al. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong. Int J Radiat Oncol Biol Phys 1989; 17: 515–30, (R2/407)
   PubMed Web of Science ®Google Scholar
• Zhang Y., Liu T., Fi C. Intracavitary radiation treatment of nasopharyngeal carcinoma by the high dose rate afterloading technique. Int J Radiat Oncol Biol Phys 1989; 16: 315–8, (R2/64)
   PubMed Web of Science ®Google Scholar
• Wang C. Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 1991; 14: 5–8, (R2/146)
   PubMed Web of Science ®Google Scholar
• Yan J., Qin D., Hu Y., et al. Management of local residual primary lesions of nasopharyngeal carcinoma: Are higher doses beneficial. Int J Radiat Oncol Biol Phys 1989; 16: 1465–9, (R2/182)
   PubMed Web of Science ®Google Scholar
• Yan J., Xu G., Hu Y., et al. Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trial on booster dose. Int J Radiat Oncol Biol Phys 1990; 18: 295–8, (C3/30)
   PubMed Web of Science ®Google Scholar
• Liu T. Trends in the clinical management of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1992; 23: 469–71, (L2)
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M., Pajak T., Cooper J., Mohiuddin M., Herskovic A., Ager P. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol 1990; 8: 1342–51, (R3/26)
   PubMed Web of Science ®Google Scholar
• Fountzilas G., Danilidis J., Kosmidis P., et al. Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases. Acta Oncol 1991; 30: 831–4, (R3/39)
   PubMed Web of Science ®Google Scholar
• Bachouchi M., Cvitkovic E., Azli N., et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy. J Natl Cancer Inst 1990; 82: 616–20, (R3/41)
   PubMedGoogle Scholar
• Harrison L., Pfister D., Bosl G. Chemotherapy as part of the initial treatment for nasopharyngeal cancer. Oncology (Williston Park) 1991; 5: 67–70, (comments: 70–71, 74. 79). (L2)
   PubMedGoogle Scholar
• Dimery I. W., Peters L. J., Goepfert H., et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993; 11: 1919–28, (P2/47)
   PubMed Web of Science ®Google Scholar
• Azli N., Armand J. P., Rahal M., Wibault P., Bousscn H., Eschwege F., Schwaab G., Gasmi J., Bachouchi M., Cvitkovic E. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type. Eur J Cancer 1992; 28A: 1792–7, (P2/30)
   PubMed Web of Science ®Google Scholar
• Rossi A., Molinari R., Boracchi P., et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988; 6: 1401–10, (C1/229)
   PubMed Web of Science ®Google Scholar
• Turner S. L., Tiver K. W. Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 27: 371–7, (P2/43)
   PubMed Web of Science ®Google Scholar
• Tsao S., Shiu W. Radiotherapy and chemotherapy for nasopharyngeal carcinoma. Ear Nose Throat J 1990; 69: 272–8, (L2)
   PubMedGoogle Scholar
• Sumitsawan Y., Lorvidhaya V., Martin N. Carcinoma of the nasopharynx in Chiang Mai University Hospital: A review of 205 cases. J Med Assoc Thai 1990; 73: 450–7, (R2/205)
   PubMedGoogle Scholar
• Tsao S. Y. Nasopharyngeal carcinoma-A review of radiotherapy techniques. Ann Acad Med 1993; 22: 638–45, (L2)
   PubMedGoogle Scholar
• Tang S., Lin F., Chen M., Liaw C., Leung W., Hong J. Prognostic factors of nasopharyngeal carcinoma. A multivariate analysis. Int J Radiat Oncol Biol Phys 1990; 19: 1143–9, (R1/561)
   PubMed Web of Science ®Google Scholar
• Luo R., Tang Q., Huang Y., Liao Y., Mou X., Hu Z. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 307–10, (R2/1882)
   PubMed Web of Science ®Google Scholar
• Mingchen Z. Results of radiotherapy in nasopharyngeal cancer. A retrospective comparison of split-course and continuous-course treatment schedules. Acta Oncol 1989; 28: 77–80, (R2/107)
   PubMed Web of Science ®Google Scholar
• Zhang E-P, Lian P-G, Cai K.-L, Chen Y-F, Cai M-D., Zheng X-F, Guang X-X. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys 1989; 16: 301–5, (R2/1302)
   PubMed Web of Science ®Google Scholar
• Wazer D., Schmidt-Ulrich R., Chasin W., Wu A., Buscher M. High-dose boost irradiation techniques for carcinoma of the nasopharynx. Am J Otolaryngol 1989; 10: 173–80, (O1)
   PubMed Web of Science ®Google Scholar
• Teo P., Tsao S., Leung S. Afterloading intracavitary radiation treatment of nasopharyngeal carcinoma. Description of a technique and preliminary treatment results. Acta Oncol 1989; 28: 525–7, (P2/73)
   PubMed Web of Science ®Google Scholar
• Erickson B. A., Wilson J. F. Nasopharyngeal brachytherapy. Am J Clin Oncol 1993; 16: 424–43, (L1)
   PubMed Web of Science ®Google Scholar
• Cooper J., Scott C., Marcial V., Griffin T., Fazekas J., Laramore G., Hoffman A. The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy Oncology Group experience. Cancer 1991; 67: 1673–7, (R2/121)
   PubMed Web of Science ®Google Scholar
• Kondziolka D., Lundsford L. Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx. Laryngoscope 1991; 101: 519–22, (O2)
   PubMed Web of Science ®Google Scholar
• Sham J., Wei W., Choy D. Ho C., Tai P., Choi P. Treatment of persistent and recurrent nasopharyngeal carcinoma by brachytherapy. Br J Radiol 1989; 62: 355–61, (P2/30)
   PubMed Web of Science ®Google Scholar
• Gao L., Xu G., Yin W., Yan J., Cai W., Gu X. Preliminary experience in HDR brachytherapy for 72 nasopharyngeal carcinoma patients. Chin Med J 1993; 106: 467–70, (R3/72)
   PubMed Web of Science ®Google Scholar
• Wei W., Sham J., Choy D., Ho C., Lam K. Split-palate approach for gold grain implantation in nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1990; 116: 578–82, (R3/23)
   PubMedGoogle Scholar
• Choy D., Sham J. S. T., Wei W. I., Ho C. M., Wu P. M. Transpalatal insertion of radioactive gold grain for the treamtent of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 25: 505–12, (R3/43)
   PubMed Web of Science ®Google Scholar
• Boussen H., Cvitkovic E., Wendling J., Azli N., Bachouchi M., Mahjoubi R., Kalifa C., Wibault P., Schwaab G., Armand J. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. J Clin Oncol 1991; 9: 1675–81, (R3/49)
   PubMed Web of Science ®Google Scholar
• Lee A. W. M., Law S. C. K., Foo W., et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: survival after local recurrence. Int J Radiat Oncol Biol Phys 1993; 26: 773–82, (R1/891)
   PubMed Web of Science ®Google Scholar
• Bradley P. Survey of current management of laryngeal and hypopharyngeal cancer. J R Coll Surg Edinb 1989; 34: 197–200, (O2)
   PubMedGoogle Scholar
• Chilla R., Nies J., Bieber J. Hypopharynxkarzinome und Radikaloperation-ein sinnvolles therapeutisches Vorgehen?. Laryngorhinootologie 1990; 69: 5–352, (R3/49)
   Google Scholar
• Fein D. A., Mendenhall W. M., Parsons J. T., Stringer S. P., Cassisi N. J., Million R. R. Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation. Int J Radiat Oncol Biol Phys 1993; 26: 751–7, (R2/99)
   PubMed Web of Science ®Google Scholar
• Timon C., Walsh M., Hennessy T. Surgical treatment of hypopharyngeal tumours. JR Coll Surg Edinb 1991; 36: 113–6, (R2/51)
   PubMedGoogle Scholar
• Slotman B. J., Kralendonk J. H., Snow G. B., Tiwari R. M., Karim ABMF. Surgery and postoperative radiotherapy and radiotherapy alone in T3-T4 cancers of the pyriform sinus. Acta Oncol 1994; 33: 55–60, (R2/54)
   PubMed Web of Science ®Google Scholar
• Kleinsasser O., Glanz H., Kimmich T. Zur Behandling der Karzinome des Sinus piriformis. HNO 1989; 37: 460–4, (R2/62)
   PubMed Web of Science ®Google Scholar
• Pradhan S. Post-cricoid cancer: an overview. Semin Surg Oncol 1989; 5: 331–6, (R2/383)
   PubMedGoogle Scholar
• Hamby L., McGrath P. C., Luce E. A., Meeker W., Kenady D. E. Optimizing primary treatment for advanced laryngeal and pyriform sinus carcinoma. Am J Surg 1992; 164: 629–33, (R3/80)
   PubMed Web of Science ®Google Scholar
• Daly N., Bachaud J., David J., Pessey J., Douchez J. Irradiation externe postoperatoire des epitheliomas epidermoides dy larynx et de l'hypopharynx. Bull Cancer 1989; 76: 745–55, (R2/138)
   PubMed Web of Science ®Google Scholar
• Bataini J. P., Brugere J., Jaulerry C. H., Brunin F., Bernier J., Ghossein N. A. Radiation treatment of lateral epilaryngeal cancer. Prognostic factors and results. Am J Clin Oncol 1984; 7: 641–5, (R2/167)
   PubMed Web of Science ®Google Scholar
• Jones A. S. The management of early hypopharyngeal cancer: primary radiotherapy and salvage surgery. Clin Otolaryngol 1992; 17: 545–9, (R2/175)
   PubMed Web of Science ®Google Scholar
• Malan J. F., Sellars S. L., Kranold D. A critical review of hypopharyngeal carcinomas-1975–1985. South Afr J Surg 1993; 31: 74–8, (R3/77)
   PubMed Web of Science ®Google Scholar
• Sailer S., Sherouse G., Chaney E., Rosenman J., Tepper J. A comparison of postoperative techniques for carcinomas of the larynx and hypopharynx using 3-D dose distributions. Int J Radiat Oncol Biol Phys 1991; 21: 767–77, (O2)
   PubMed Web of Science ®Google Scholar
• Guerrier B., Balmigere G., Daures J., Lallemant J., Guerrier Y. Cancer of the laryngeal vestibule. A retrospective study of 161 cases. Arch Otorhinolaryngol 1989; 246: 378–81, (R2/161)
   PubMedGoogle Scholar
• DeSanto L. Early supraglottic cancer. Ann Otol Rhinol Laryngol 1990; 99: 593–7, (R2/94)
   PubMed Web of Science ®Google Scholar
• Nikolaou A., Daniilidis J., Fountzilas G., Kouloulas A., Som-Bolos K, Velegrakis G. Supraglottic laryngectomy: experience with 66 patients over 20 years. J Laryngol Otol 1993; 107: 813–6, (R2/66)
   PubMed Web of Science ®Google Scholar
• Mendenhall W., Parsons J., Stringer S., Cassisi N., Million R. The role of radiation therapy in laryngeal cancer. CA Cancer J Clin 1990; 40: 150–65, (L2)
   PubMed Web of Science ®Google Scholar
• Bataini J. P., Ennuyer A., Poncet P., Ghossein N. A. Treatment of supraglottic cancer by radical high dose radiotherapy. Cancer 1974; 33: 1253–62, (R2/218)
   PubMed Web of Science ®Google Scholar
• Zamora R. L., Harvey J. E., Sessions D. G., Spitznagel E. L. Clinical staging for primary malignancies of the supraglottic larynx. Laryngoscope 1993; 103: 69–77, (R1/520)
   PubMed Web of Science ®Google Scholar
• Devineni V., Simpson J., Sessions D., Spector J., Hayden R., Fredrickson J., Fineberg B. Supraglottic carcinoma: impact of radiation therapy on outcome of patients with positive margins and extracapsular nodal disease. Laryngoscope 1991; 101: 767–70, (R2/79)
   PubMed Web of Science ®Google Scholar
• Davis R. K., Shapshay S. M., Strong M. S., Hyams V. J. Transoral partial supraglottic resection using the CO2 laser. Laryngoscope 1983; 93: 429–32, (P3/20)
   PubMed Web of Science ®Google Scholar
• Barthes M., Bolla M., Lavieille J., Bensoussan S., Junien-Lavillauroy C. Les cancers du vestibule larynge: resultats et indications therapeutiques a propos de 124 cas. Rev Laryngol Otol Rhinol (Bord) 1990; 111: 45–9, (R2/124)
   PubMedGoogle Scholar
• Shimm D., Coulthard S. Radiation therapy for squamous cell carcinoma of the supraglottic larynx. Am J Clin Oncol 1989; 12: 17–23, (R2/65)
   PubMed Web of Science ®Google Scholar
• Inoue T., Matayoshi Y., Inoue T., Ikeda H., Teshima T., Murayama S. Prognostic factors in telecobalt therapy for early supraglottic carcinoma. Cancer 1993; 72: 57–61, (R2/100)
   PubMed Web of Science ®Google Scholar
• McLean M. Primary management of limited laryngeal cancer by radiotherapy and surgical salvage: results of 164 cases treated in a district hospital. Clin Oncol (R Coll Radiol) 1989; 1: 97–100, (R2/164)
   PubMedGoogle Scholar
• Croll G., Gerritsen G., Tiwari R., Snow G. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Results and complications. Eur J Surg Oncol 1989; 15: 350–6, (R2/58)
   PubMed Web of Science ®Google Scholar
• Wang M., Lavey R., Calcaterra T. Efficacy and morbidity of partial laryngectomy and postoperative radiation therapy. Laryngoscope 1990; 100: 1146–51, (R3/24)
   PubMed Web of Science ®Google Scholar
• Wang C., Montgomery W. Deciding on optimal management of supraglottic carcinoma. Oncology (Huntingt) 1991; 5: 41–6, (discussion 49. 53). (O2)
   PubMedGoogle Scholar
• Van Acht M., Hermans J., Dolsma W., Hulshof J., Leer J. Glottic and supraglottic carcinoma: a retrospective comparison of radiotherapy alone with sandwich therapy in 366 patients. Radiother Oncol 1989; 14: 103–12, (R2/366)
   PubMed Web of Science ®Google Scholar
• Mendenhall W., Parsons J., Stringer S., Cassisi N., Million R. Carcinoma of the supraglottic larynx: a basis for comparing the results of radiotherapy and surgery. Head Neck 1990; 12: 204–9, (R2/129)
   PubMed Web of Science ®Google Scholar
• Schwerdtfeger F., Dornoff W., Gosepath J. Behandlungsresultate nach supraglottischer Kehlkopfteilresektion bei Karzinomen des Larynxeingangs des Zungengrundes und des Hypopharynx. 2. Teil: Bestrahlungstherepie und Spätresultate nach chirurgisch-radiol. Laryngorhinootologie 1991; 70: 307–11, (R2/110)
   Google Scholar
• Fietkau R., Sauer R. Möglichkeiten und Grenzen der Radiotherapie des Larynxkarzinoms. Strahlenther Onkol 1992; 168: 1–16, (L1)
   PubMedGoogle Scholar
• Inoue T., Inoue T., Ikeda H., et al. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy. Strahlenther Onkol 1993; 169: 584–9, (R2/338)
   PubMedGoogle Scholar
• Bradley P., Morgan D. Radiotherapy of advanced laryngeal cancer using three small fractions daily. Otolaryngol Head Neck Surg 1991; 104: 838–41, (P1/26)
   PubMed Web of Science ®Google Scholar
• Wendt C., Peters L., Ang K., Morrison W., Maor M., Goepfert H, Oswald M. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1989; 17: 1057–62, (P2/41)
   PubMed Web of Science ®Google Scholar
• Shaw H. Role of partial laryngectomy after irradiation in the treatment of laryngeal cancer: a view from the United Kingdom. Ann Otol Rhinol Laryngol 1991; 100(4 Pt 1)268–73, (R2/118)
   PubMed Web of Science ®Google Scholar
• Lindelöv B., Hansen H. Advanced squamous cell carcinoma of the larynx. Acta Oncol 1990; 29: 505–8, (R2/676)
   PubMed Web of Science ®Google Scholar
• O'Sullivan B. O., Mackillop W., Gilbert R., Gaze M., Lundgren J., Atkinson C., Wynne C., Fu H. Controversies in the management of laryngeal cancer: results of an international survey of patterns of care. Radiother Oncol 1994; 31: 23–32, (O1)
   PubMed Web of Science ®Google Scholar
• Fernberg J., Ringborg U., Silfverswärd C., Ewert G., Haglund S., Schiratzki H., Strander H. Radiation therapy in early glottic cancer. Analysis of 177 consecutive cases. Acta Otolaryngol (Stockh) 1989; 108: 478–81, (R3/177)
   PubMed Web of Science ®Google Scholar
• MacLeod P., Daniel F. The role of radiotherapy in in-situ carcinoma of the larynx. Int J Radiat Oncol Biol Ph; 1990; 18: 113–7, (R2/91)
   PubMed Web of Science ®Google Scholar
• Smith R., Lockey M. Carcinoma in situ and T1 squamous cell carcinoma of the glottis: The Mississippi Baptist Medical Center experience. J Miss State Med Assoc 1989; 30: 365–70, (R2/62)
   PubMedGoogle Scholar
• Murty G. E., Diver J. P., Bradley P. J. Carcinoma in situ of the glottis: radiotherapy or excision biopsy. Ann Otol Rhinol Laryngol 1993; 102: 592–5, (R3/37)
   PubMed Web of Science ®Google Scholar
• Fein D. A., Mendenhall W. M., Parsons J. T., Stringer S. P., Cassisi N. J., Million R. R. Carcinoma in situ of the glottic larynx: the role of radiotherapy. Int J Radiat Oncol Biol Phys 1993; 27: 379–84, (R2/19)
   PubMed Web of Science ®Google Scholar
• Small W., Mittal B. B., Brand W. N., et al. Role of radiation therapy in the management of carcinoma in situ of the larynx. Laryngoscope 1993; 103: 663–7, (R3/21)
   PubMed Web of Science ®Google Scholar
• Flentje M., Wannenmacher M. Strahlentherapie des Kehlkopfkarzinoms. Radiologe 1991; 31: 332–8, (L1)
   PubMed Web of Science ®Google Scholar
• Kelly M., Hahn S., Spaulding C., Kersh C., Constable W., Cantrell R. Definitive radiotherapy in the management of stage I and II carcinomas of the glottis. Ann Otol Rhinol Laryngol 1989; 98: 235–9, (R2/187)
   PubMed Web of Science ®Google Scholar
• Pellitteri P., Kennedy T., Vrabec D., Beiler D., Hellstrom M. Radiotherapy. The mainstay in the treatment of early glottic carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117: 297–301, (R1/185)
   PubMedGoogle Scholar
• Robson N., Oswal V., Flood L. Radiation therapy of laryngeal cancer: a twenty year experience. J Laryngol Otol 1990; 104: 699–703, (R 2/286)
   PubMed Web of Science ®Google Scholar
• Schwerdtfeger F., Dornoff W., Gosepath J. Die primär kurative Strahlentherapie kleiner Stimmbandkarzinome. Eine Langzeitstudie mit Verlaufsbeobachtungen: über 2 bis 14 Jahre. Laryngorhinootologie 1990; 69: 308–11, (R2/92)
   PubMed Web of Science ®Google Scholar
• Daniilidis J., Nikolaou A, Symeonidis V. Our experience in the surgical treatment of Tl carcinoma of the vocal cord. J Laryngol Otol 1990; 104: 222–4, (R2/94)
   PubMed Web of Science ®Google Scholar
• Glanz H., Kimmich T., Eichhorn T., Kleinsasser O. Behand-lungsergebnisse bei 584 Kehlkopfcarcinomen an der Hals-Nasen-Ohrenklinik der Universitat Marburg. HNO 1989; 37: 1–10, (R2/584)
   PubMed Web of Science ®Google Scholar
• Ton-Van J., Lefebvre J., Stern J., Buisset E., Coche-Dequeant B., Vankemmel B. Comparison of surgery and radiotherapy in T1 and T2 glottic carcinomas. Am J Surg 1991; 162: 337–40, (R3/356)
   PubMed Web of Science ®Google Scholar
• Kowalski L. P., Batista M. B. P., Santos C. R., et al. Prognostic factors in glottic carcinoma clinical stage I and II treated by surgery or radiotherapy. Am J Otolaryngol 1993; 14: 122–7, (R2/145)
   PubMed Web of Science ®Google Scholar
• Myssiorek D. The role of surgery in early stage glottic carcinoma. Cancer Invest 1992; 10: 391–8, (L1)
   PubMed Web of Science ®Google Scholar
• Olsen K. D., Thomas J. V., Desanto L. W., Suman V. J. Indications and results of cordectomy for early glottic carcinoma. Otolaryngol Head Neck Surg 1993; 108: 277–82, (R2/95)
   PubMed Web of Science ®Google Scholar
• Stalpers L., Verbeek A., Van Daal W. Radiotherapy or surgery for T2N0M0 glottic carcinoma? A decision-analytic approach. Radiother Oncol 1989; 14: 209–17, (O1)
   PubMed Web of Science ®Google Scholar
• Zablow A., Erba P, Sanfillippo L. Radiotherapy T2 glottic carcinoma. N J Med 1989; 86: 879–82, (R2/63)
   PubMedGoogle Scholar
• Mendenhall W. M., Parsons J. T., Million R. R. Management of T1 and T2 squamous cell carcinoma of the glottic larynx. Mayo Clin Proc 1992; 67: 703–5, (R2/304)
   PubMed Web of Science ®Google Scholar
• Million R. R. Carcinomas of the larynx and hypopharynx. Meyer JL Vaeth J. M. eds: Organ Conservation in Curative Cancer Treatment. Front Radiat Ther Oncol. Baser Karger 1993; 27: 31–40, (L2)
   Google Scholar
• Hoyt D. J., Lettinga J. W., Leopold K. A., Fisher S. R. The effect of head and neck radiation therapy on voice quality. Laryngoscope 1992; 102: 477–80, (P2/25)
   PubMed Web of Science ®Google Scholar
• Tsuji D., Fukuda H., Kawasaki Y., Kawaida M, Kanzaki J. A clinical study on T1 glottic cancer treated by laser technique. Keio J Med 1989; 38: 413–8, (R3/40)
   PubMedGoogle Scholar
• Epstein B., Lee D., Kashima H., Johns M. Stage T1 glottic carcinoma: results of radiation therapy or laser excision. Radiology 1990; 175: 567–70, (R2/77)
   PubMed Web of Science ®Google Scholar
• Cragle S. P., Brandenburg J. H. Laser cordectomy or radiotherapy: cure rates communication and cost. Otolaryngol Head Neck Surg 1993; 108: 648–54, (M2/3499)
   PubMed Web of Science ®Google Scholar
• Eckel H. E., Thumfart W. F. Laser surgery for the treatment of larynx carcinomas: indications techniques and preliminary results. Ann Otol Rhinol Laryngol 1992; 101: 113–8, (R2/110)
   PubMed Web of Science ®Google Scholar
• Cellai E., Chiavacci A., Olmi P. Causes of failure of curative radiation therapy in 205 early glottic cancers. Int J Radiat Oncol Biol Phys 1990; 19: 1139–42, (R2/205)
   PubMed Web of Science ®Google Scholar
• Turner S., Tiver K. Radical radiotherapy for carcinoma of the larynx-Westmead Hospital experience. Austr Radiol 1991; 35: 242–7, (R2/141)
   PubMedGoogle Scholar
• Teshima T., Chatani M., Inoue T. Radiation therapy for early glottic cancer (T1N0M0): I. Results of conventional open field technique. Int J Radiat Oncol Biol Phys 1989; 17: 1199–202, (R2/91)
   PubMed Web of Science ®Google Scholar
• Johansen L., Overgaard J., Hjelm-Hansen M., Gadeberg C. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 1990; 18: 1307–13, (R2/478)
   PubMed Web of Science ®Google Scholar
• Lustig R., Krall J., Curran W., Hanks G. Improvements observed in care and outcome in carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991; 20: 101–4, (R2/521)
   PubMed Web of Science ®Google Scholar
• Terhaard C., Snippe K., Ravasz L., van der Tweel I., Hordijk G. Radiotherapy in T1 laryngeal cancer: Prognostic factors for locoregional control and survival uni- and multivariate analysis. Int J Radiat Oncol Biol Phys 1991; 21: 1179–86, (R1/194)
   PubMed Web of Science ®Google Scholar
• Stein M., Rosenblatt E., Kuten A., Cohen Y. Results of radiation therapy in early glottic carcinoma (T1. T2 NO). J Surg Oncol 1989; 40: 173–6, (R3/60)
   PubMed Web of Science ®Google Scholar
• Turesson I., Sandberg N., Mercke C., Johansson K., Sandin I., Wallgren A. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns. Acta Oncol 1991; 30: 357–62, (R2/302)
   PubMed Web of Science ®Google Scholar
• Chatani M., Matayoshi Y., Masaki N. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma. Strahlenlher Onkol 1993; 169: 102–6, (R2/95)
   PubMedGoogle Scholar
• De Schryver A. Radiotherapy of laryngeal cancer. General principles and results in T1 and T2 cases. Acta Oto-rhinolaryngol Belg 1992; 46: 187–95, (L2)
   PubMedGoogle Scholar
• Small W., Mittal B. B., Brand W. N., et al. Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables. Radiol 1992; 183: 789–94, (R1/103)
   PubMed Web of Science ®Google Scholar
• Lusinchi A., Dube P., Wibault P., Kunkler I., Luboinski B., Eschwege F. Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiother Oncol 1989; 15: 313–9, (R2/197)
   PubMed Web of Science ®Google Scholar
• Kob D., Quade K, Gramowski K., Haas D. Ergebnisse der operativ-radiologischen Behandlungsstrategie bei Larynxkarzinomen in Jenaer Patientenmaterial von 1964 bis 1981. Radiobiol Radiother 1989; 30: 31–8, (R2/452)
   PubMedGoogle Scholar
• Trassera J., Avellaneda R., Cuchi A., Arias C. Caractéristiques évolutives du cancer glottique. Ann Oto Laryng 1989; 106: 91–6, (R2/302)
   PubMedGoogle Scholar
• Inoue T., Inoue T., Ikeda H., Teshima T., Murayama S. Prognostic factor of telecobalt therapy for early glottic carcinoma. Cancer 1992; 70: 2797–801, (R2/330)
   PubMed Web of Science ®Google Scholar
• Rucci L., Gallo O, Fini-Storchi O. Glottic cancer involving anterior commissure: surgery vs radiotherapy. Head Neck 1991; 13: 403–10, (R2/182)
   PubMed Web of Science ®Google Scholar
• Zohar Y., Rahima M., Shvili Y., Talmi Y., Lurie H. The controversial treatment of anterior commissure carcinoma of the larynx. Laryngoscope 1992; 102: 69–72, (R2/67)
   PubMed Web of Science ®Google Scholar
• Stevenson J., Juillard G, Selch M. Stages 1 and 2 epidermoid carcinoma of the glottic larynx: involvement of the anterior commissure. Radiology 1992; 182: 797–9, (R3/55)
   PubMed Web of Science ®Google Scholar
• Vermund H., Boysen M., Brandenburg J., et al. Primary irradiation surgery or combined therapy in squamous cell carcinoma of the larynx. A comparison of treatment results from two centers. Acta Oncol 1990; 29: 489–503, (R1/730)
   PubMed Web of Science ®Google Scholar
• Sandberg N., Mercke C., Turesson I. Glottic laryngeal carcinoma with fixed vocal cord treated with full-dose radiation total laryngectomy or combined treatment. Acta Oncol 1990; 29: 509–11, (R3/46)
   PubMed Web of Science ®Google Scholar
• Guiney M., Smith J., Hughes P., Narayan K. Radiation therapy of glottic carcinoma: Peter MacCallum Cancer Institute experience. Aust N Z J Surg 1992; 62: 622–7, (R2/127)
   PubMedGoogle Scholar
• Jones A. S., Cook J. A., Phillips D. E., Soler Lluch E. Treatment of T3carcinoma of the larynx by surgery or radiotherapy. Clin Otolaryngol 1992; 17: 433–6, (R2/147)
   PubMed Web of Science ®Google Scholar
• Rockley T., Robin P., Powell J., McConkey C. Primary treatment of cancer of the larynx. J Laryngol Otol 1991; 105: 459–62, (R1/3445)
   PubMed Web of Science ®Google Scholar
• Reddy K. T. V., Vinayak B. C., Jefferis A. F., Wallace M. Primary radiotherapy for treating all laryngeal cancer: a district hospital experience. J Laryngol Otol 1993; 107: 454–6, (R3/85)
   Web of Science ®Google Scholar
• Lee W. R., Mancuso A. A., Saleh E. M., Mendenhall W. M., Parsons J. T., Million R. R. Can pretreatment computed tomography findings predict local control in T3squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?. Int J Radiat Oncol Biol Phys 1993; 25: 683–7, (R2/29)
   PubMed Web of Science ®Google Scholar
• Levendag P. C., Ravasz L. A., Terhaard C. H. J., Hordijk G. J. T3squamous cell carcinoma of the larynx treated by a splitcourse radiation protocol. Am J Clin Oncol 1993; 16: 509–18, (R2/131)
   PubMed Web of Science ®Google Scholar
• Tennvall J., Wennerberg J., Willén R., Ask A., Baldetorp B., Fernö M. T3N0 glottic carcinoma: DNA S-phase as a predictor of the outcome after radiotherapy. Acta Otolaryngol (Stockh) 1993; 113: 220–4, (R2/23)
   PubMed Web of Science ®Google Scholar
• Terhaard C., Karim A., Hoogenraad W., et al. Local control in T3laryngeal cancer treated with radical radiotherapy time dose relationship: the concept of nominal standard dose and linear quadratic model. Int J Radiat Oncol Biol Phys 1991; 20: 1207–14, (R2/104)
   PubMed Web of Science ®Google Scholar
• Wiggenraad R., Terhaard C., Hordijk G., Ravasz L. The importance of vocal cord mobility in T2larynx cancer. Radiother Oncol 1990; 18: 321–7, (R2/75)
   PubMed Web of Science ®Google Scholar
• Cano E., Flickinger J., Johnson J. Multivariate analysis results of radiotherapy for laryngeal cancer. Head Neck 1993; 15: 382–8, (R3/80)
   PubMed Web of Science ®Google Scholar
• Inoue T., Inoue T., Chatani M., Teshima T. Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma. Strahlenther Onkol 1992; 168: 23–6, (C3/116)
   PubMedGoogle Scholar
• Krawczyk J., Svoboda V., Foster L. The influence of some factors on local control of early glottic cancer. Clin Oncol (R Coll Radiol) 1991; 3: 330–4, (R1/122)
   PubMedGoogle Scholar
• Lindelöv B., Lauritzen A., Hansen H. Stage I glottic carcinoma: an analysis of tumour recurrence after primary radiotherapy. Clin Oncol (R Coll Radiol) 1990; 2: 94–6, (R2/145)
   PubMedGoogle Scholar
• Kim R., Marks M., Salter M. Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology 1992; 182: 273–5, (R2/85)
   PubMed Web of Science ®Google Scholar
• Rudoltz M. S., Benammar A., Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 1993; 26: 767–72, (R1/91)
   PubMed Web of Science ®Google Scholar
• Fein D. A., Mendenhall W. M., Parsons J. T., Million R. R. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 1993; 25: 605–11, (R1/247)
   PubMed Web of Science ®Google Scholar
• Izuno I., Sone S., Oguchi M., Kiyono K., Takei K. Treatment of early vocal cord carcinoma with 60Co gamma rays, 8/10 Mv x-rays, or 4 MV x-rays-are the results different? Letter. Acta Oncol 1990; 29: 637–9, (R2/245)
   PubMed Web of Science ®Google Scholar
• Hayakawa K., Mitsuhashi N., Tamaki Y., et al. Radiation therapy for stage I and II laryngeal cancer using 10 MV x-rays or Cobalt-60 rays. Radiat Med 1992; 10: 199–205, (R2/117)
   PubMedGoogle Scholar
• Akine Y., Tokita N., Ogino T., et al. Radiotherapy of T1 glottic cancer with 6 MeV x rays. Int J Radiat Oncol Biol Phys 1991; 20: 1215–8, (R2/154)
   PubMed Web of Science ®Google Scholar
• Foote R. L., Olsen K. D., Kunselman S. J., et al. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc 1992; 67: 629–36, (R3/45)
   PubMed Web of Science ®Google Scholar
• Hammer J., Hochleitner F., Meindl J., Seewald D., Track C., Kundrath E. Kombinierte externe und interstitielle Radiotherapie des Stimmbandkarzinoms. Strahlenther Onkol 1991; 167: 277–81, (P2/16)
   PubMedGoogle Scholar
• Balla M., Polyzoidis T. Die Radiumkontaktbestrahlung des Stimmbandkarzinoms-eine mögliche Behandlungsmethode?. Strahlenther Onkol 1990; 166: 132–4, (R3/113)
   PubMed Web of Science ®Google Scholar
• Kersh C., Kelly M., Hahn S., Spaulding C., Cantrell R., Constable W. Early glottic carcinoma: patterns and predictors of relapse after definitive radiotherapy: see comments. South Med J 1990; 83: 374–8, (R1/148)
   PubMed Web of Science ®Google Scholar
• Parsons J., Mendenhall W., Mancuso A., Cassisi N., Stringer S., Million R. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck 1989; 11: 123–8, (P2/21)
   PubMed Web of Science ®Google Scholar
• Mendenhall W. M., Parsons JT, Stringer S. P., Cassisi N. J., Million R. R. Stage T3 squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phys 1992; 23: 725–32, (R2/118)
   PubMed Web of Science ®Google Scholar
• Rothfield R., Johnson J., Myers E., Wagner R. Hemilaryngectomy for salvage of radiation therapy failures. Otolaryngol Head Neck Surg 1990; 103: 792–4, (R3/14)
   PubMed Web of Science ®Google Scholar
• Howell-Burke D., Peters L., Goepfert H., Oswald M. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg 1990; 116: 830–5, (R2/114)
   PubMedGoogle Scholar
• Maipang T., Razack M., Sako K., Chen T. Surgical salvage for recurrent “early” glottic cancers. J Surg Oncol 1989; 40: 32–3, (R2/143)
   PubMed Web of Science ®Google Scholar
• Mendenhall W., Parsons J., Brant T., Stringer S., Cassisi N., Million R. Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottic larynx?. Radiother Oncol 1989; 14: 199–202, (R2/98)
   PubMed Web of Science ®Google Scholar
• Wang C. C., McIntyre J. Re-irradiation of laryngeal carcinoma-techniques and results. Int J Radiat Oncol Biol Phys 1993; 26: 783–5, (R3/20)
   PubMed Web of Science ®Google Scholar
• Lavey R., Calcaterra T. Partial laryngectomy for glottic cancer after high-dose radiotherapy. Am J Surg 1991; 162: 341–4, (R3/25)
   PubMed Web of Science ®Google Scholar
• Crellin R. P., Gaze M. N., White A., Maran A. G. D., Macdougall R. H. Salvage laryngectomy after radical radiotherapy for laryngeal carcinoma. Clin Otolaryngol 1992; 17: 449–51, (R3/56)
   PubMed Web of Science ®Google Scholar
• Viani L., Stell P., Dalby J. Recurrence after radiotherapy for glottic carcinoma. Cancer 1991; 67: 577–84, (R1/478)
   PubMed Web of Science ®Google Scholar
• McCombe A. W., Jones A. S. Radiotherapy and complications of laryngectomy. J Laryngol Otol 1993; 107: 130–2, (R2/357)
   PubMed Web of Science ®Google Scholar
• Razack M., Maipang T., Sako K., Bakamjian V., Shedd D. Management of advanced glottic carcinomas. Am J Surg 1989; 158: 318–20, (R2/128)
   PubMed Web of Science ®Google Scholar
• Kerrebijn J. D. F., de Boer M. F., Knegt P. P. CO2-laser treatment of recurrent glottic carcinoma. Clin Otolaryngol 1992; 17: 430–2, (R3/23)
   PubMed Web of Science ®Google Scholar
• Guedea F., Parsons J., Mendenhall W., Million R., Stringer S., Cassisi N. Primary subglottic cancer: results of radical radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 1607–11, (O3)
   PubMed Web of Science ®Google Scholar
• Haylock B. J., Deutsch G. P. Primary radiotherapy for subglottic carcinoma. Clin Oncol 1993; 5: 143–6, (R3/23)
   PubMedGoogle Scholar
• Coia L., Galvin J., Sontag M., et al. Three-dimensional photon treatment planning in carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991; 21: 183–92, (O1)
   PubMed Web of Science ®Google Scholar
• Freeman D., Manusco A., Parsons J., Mendenhall W, Million R. Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results: see comments. Int J Radiat Oncol Biol Phys 1990; 19: 485–90, 497-8. (R2/54)
   PubMed Web of Science ®Google Scholar
• Karim A., Kralendonk J., Njo K., Tabak M., Gort G. A critical look at the TNM classification for laryngeal carcinoma. Cancer 1990; 65: 1918–22, (P1/564)
   PubMed Web of Science ®Google Scholar
• Kuchnir F., Heffron J., Myrianthopoulos L., Haraf D. Beam's-eye-view aided treatment planning for a nasopharyngeal lesion: a case report. Med Dosim 1989; 14: 231–5, (O2)
   PubMedGoogle Scholar
• Kutcher G., Fuks Z., Brenner H., et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991; 21: 169–82, (O2)
   PubMed Web of Science ®Google Scholar
• Kraiphibul P., Atichartakarn V. Treatment of nasopharyngeal carcinoma. J Med Assoc Thai 1992; 75: 435–44, (L1)
   PubMedGoogle Scholar
• Koukourakis M. I., Varveris H. A., Helidonis E. S., Gourtsogiannis N. H. CT-based radiotherapy treatment planning for cancer of the nasopharynx. Comput Med Imaging Graph 1993; 17: 81–7, (R3/32)
   PubMed Web of Science ®Google Scholar
• Leibel S., Kutcher G., Harrison L., Fass D., Burman C., Hunt M., Mohan R., Brewster L., Ling C., Fuks Z. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991; 20: 823–33, (O2)
   PubMed Web of Science ®Google Scholar
• Leibel S., Ling C., Kutcher G., Mohan R., Cordon-Cordo C., Fuks Z. The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 805–11, (O2)
   PubMed Web of Science ®Google Scholar
• Vijayakumar S., Low N., Chen G., et al. Beams eye viewbased photon radiotherapy I. Int J Radiat Oncol Biol Phys 1991; 21: 1575–86, (O1)
   PubMed Web of Science ®Google Scholar
• Ésik O., Schlegel W., Boesecke R., Nmeth G., Lorenz W. Three-dimensional photon radiotherapy planning for laryngeal and hypopharyngeal cancers. I. Conventional rotational technique. Radiother Oncol 1991; 20: 229–37, (O2)
   PubMed Web of Science ®Google Scholar
• Ésik O., Bürkelbach J., Boesecke R., Schlegel W., Nemeth G., Lorentz WJ. Three-dimensional photon radiotherapy planning for laryngeal and hypopharyngeal cancers. Conformation treatment planning using a multileaf collimator. Radiother Oncol 1991; 20: 238–44, (O2)
   PubMed Web of Science ®Google Scholar
• LoSasso T., Chui C. S., Kutcher G. J., Leibel S. A., Fuks Z, Ling C. C. The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. Int J Radiat Oncol Biol Phys 1993; 25: 161–70, (O3)
   PubMed Web of Science ®Google Scholar
• Lane R., Loyd M., Chow C., Ekwelundu E, Rosen I. Improved dose homogeneity in the head and neck using computer controlled radiation therapy. Int J Radiat Oncol Biol Phys 1990; 19: 1531–8, (O2)
   PubMed Web of Science ®Google Scholar
• Keus R., Noach P., de Boer R., Lebesque J. The effect of customized beam shaping on normal tissue complications in radiation therapy of parotid gland tumors. Radiother Oncol 1991; 21: 211–7, (O1)
   PubMed Web of Science ®Google Scholar
• Kutcher G., Burman C., Brewster L., Goitein M., Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991; 21: 137–46, (O1)
   PubMed Web of Science ®Google Scholar
• Niemierko A., Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol 1991; 20: 166–76, (O1)
   PubMed Web of Science ®Google Scholar
• Drzymala R., Mohan R., Brewster L., Chu J., Goitein M., Harms W., Urie M. Dose-volume histograms. Int J Radiat Oncol Biol Phys 1991; 21: 71–78, (O2)
   PubMed Web of Science ®Google Scholar
• Mitine C., Leunens G., Verstraete J., et al. Is it necessary to repeat quality control procedures for head and neck patients. Radiother Oncol 1991; 21: 210–10, (O1)
   Web of Science ®Google Scholar
• Hunt M. A., Kutcher G. J., Burman C., et al. The effect of setup uncertainties on the treatment of nasopharynx cancer. Int J Radiat Oncol Biol Phys 1993; 27: 437–47, (O2)
   PubMed Web of Science ®Google Scholar
• Meertens H., Van Herk M., Bijhold J, Bartelink H. First clinical experience with a newly developed electronic portal imaging device. Int J Radiat Oncol Biol Phys 1990; 18: 1173–81, (O2)
   PubMed Web of Science ®Google Scholar
• Wade P., Nicholas D. Clinical application of an electronic imaging device for assisting patient set-up in radiotherapy. Br J Radiol 1991; 64: 596–602, (O2)
   PubMed Web of Science ®Google Scholar
• Slater J. M., Slater J. D., Archambeau J. O. Carcinoma of the tonsillar region: Potential for use of proton beam therapy. Int J Radiat Oncol Biol Phys 1991; 22: 311–9, (O1)
   Web of Science ®Google Scholar
• Hayes J., Moeller J., Leavitt D., Davis R., Harnsberger H. Computed tomography treatment planning in IR-192 brachytherapy in the head and neck. Int J Radiat Oncol Biol Phys 1992; 22: 181–9, (O1)
   PubMed Web of Science ®Google Scholar
• Hoshina M., Shibuya H., Horiuchi J., Matsubara S., Suzuki S., Takeda M. Discriminant analysis of the treatment results of interstitial radium tongue implants. Br J Radiol 1989; 62: 59–63, (O1)
   PubMed Web of Science ®Google Scholar
• Photon Treatment Planning Collaborative Working Group. State-of-the-art of external photon beam radiation treatment planning. Int J Radiat Oncol Biol Phys 1991; 21: 9–23, (O1)
   PubMed Web of Science ®Google Scholar
• Photon Treatment Planning Collaborative Working Group. Three-dimensional dose calculations for radiation treatment planning. Int J Radiat Oncol Biol Phys 1991; 21: 25–36, (O1)
   PubMed Web of Science ®Google Scholar
• Photon Treatment Planning Collaborative Working Group. Three-dimensional display in planning radiation therapy: a clinical perspective. Int J Radiat Oncol Biol Phys 1991; 21(1)79–89, (O2)
   PubMed Web of Science ®Google Scholar
• Photon Treatment Planning Collaborative Working Group. The clinical three-dimensional treatment planning studies: a prologue. Int J Radiat Oncol Biol Phys 1991; 21: 165–7, (O3)
   PubMed Web of Science ®Google Scholar
• Wiernik G., Alcock C., Bates T., et al. Final report of the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol 1991; 64: 232–41, (C2/734)
   PubMed Web of Science ®Google Scholar
• Parsons J. T., Bova F. J., Million R. R. A re-evaluation of splitcourse technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1980; 6: 1645–52, (R1/468)
   PubMed Web of Science ®Google Scholar
• Maciejewski B., Preuss-Bayer G., Trott K-R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983; 9: 321–8, (R2/310)
   PubMed Web of Science ®Google Scholar
• Pajak T., Laramore G., Marcial V., et al. Elapsed treatment days-A critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 1991; 20: 13–20, (M1/426)
   PubMed Web of Science ®Google Scholar
• Van Putten W. L. J., van der Sangen M. J. C., Hoekstra C. J. M., Levendag P. C. Dose fractionation and overall treatment time in radiation therapy-the effects on local control for cancer of the larynx. Radiother Oncol 1994; 30: 97–108, (R1/997)
   PubMed Web of Science ®Google Scholar
• Lindstrom M., Fowler J. Re-analysis of the time factor in local control by radiotherapy of T3T4squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991; 21: 813–7, (O1)
   PubMed Web of Science ®Google Scholar
• Rezvani M., Fowler J. F., Hopewell J. W., Alcock C. J. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy. Br J Radiol 1993; 66: 245–55, (O2)
   PubMed Web of Science ®Google Scholar
• Robertson A. G., Robertson C., Boyle P., Symonds R. P., Wheldon T. E. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993; 29A: 501–10, (R2/336)
   PubMed Web of Science ®Google Scholar
• Maciejewski B., Withers H., Taylor J., Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 1989; 16: 831–43, (R1/498)
   PubMed Web of Science ®Google Scholar
• Bentzen S., Johansen L., Overgaard J., Thames H. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Rad Oncol Biol Phys 1991; 20: 1197–206, (R1/181)
   PubMed Web of Science ®Google Scholar
• Slevin N., Hendry J., Roberts S., Agren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 1992; 24: 215–20, (R1/496)
   PubMed Web of Science ®Google Scholar
• Hendry J. H., Roberts S. A., Slevin N. J., Keane T. J., Barton M. B., Ågren-Cronqvist A. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol 1994; 31: 14–22, (R1/1497)
   PubMed Web of Science ®Google Scholar
• Barton M. B., Keane T. J., Gadalla T., Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 23: 137–43, (R1/1012)
   PubMed Web of Science ®Google Scholar
• Taylor J. M. G., Withers H. R., Mendenhall W. M. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990; 17: 95–102, (O2)
   PubMed Web of Science ®Google Scholar
• Withers H. R., Taylor J. M. G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46, (O1)
   PubMed Web of Science ®Google Scholar
• Fowler J. Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment-continually rapid proliferation unmasked. Radiother Oncol 1991; 22: 156–8, (O2)
   PubMedGoogle Scholar
• Bentzen S., Thames H. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol 1991; 22: 161–6, (O2)
   PubMed Web of Science ®Google Scholar
• Trott K., Kummermehr J. Rapid repopulation in radiotherapy: A debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 1991; 22: 159–60, (O2)
   PubMed Web of Science ®Google Scholar
• Maciejewski B., Zajusz A., Rota L. ROC analysis of benefit and limitation in radiotherapy for cancer of the oral cavity. Neoplasma 1993; 40: 181–4, (O2)
   PubMed Web of Science ®Google Scholar
• Fowler J. Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer. Int J Radiat Oncol Biol Phys 1991; 21: 1451–6, (O2)
   PubMed Web of Science ®Google Scholar
• Thames H. D., Withers H. R., Peters L. J., Fletcher G. H. Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8: 219–26, (O1)
   PubMed Web of Science ®Google Scholar
• Taylor J., Mendenhall W., Lavey R. Dose time and fraction size issues for late effects in head and neck cancers. Int J Radiat Oncol Biol Phys 1992; 22: 3–11, (R1/784)
   PubMed Web of Science ®Google Scholar
• Wiernik G., Bates T., Bleehen N., et al. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx: see comments. Br J Radiol 1990; 63: 169–80, 315-6. (C2/734)
   PubMed Web of Science ®Google Scholar
• Randall M., Springer D., Raben M. T1-T2carcinoma of the glottis: Relative hypofractionation. Radiol 1991; 179: 569–71, (R2/90)
   PubMed Web of Science ®Google Scholar
• Rezvani M., Alcock C., Fowler J., Haybittle J., Hopewell J., Wiernik G. Normal tissue reactions in the British Institute of Radiology Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the laryngo-pharynx by radiotherapy. Br J Radiol 1991; 64: 1122–33, (C2/734)
   PubMed Web of Science ®Google Scholar
• Lee P., Hung B., Woo E., Tai P., Choi D. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg and Psychiatry 1989; 52: 488–92, (P1/16)
   PubMed Web of Science ®Google Scholar
• Lee A. W. M., Law S. C. K., Ng S. H., et al. Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985: late complications following megavoltage irradiation. Br J Radiol 1992; 65: 918–28, (R1/4527)
   PubMed Web of Science ®Google Scholar
• Weissberg J., Son Y., Percarpio B., Fischer J. Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1982; 8: 179–85, (C3/64)
   PubMed Web of Science ®Google Scholar
• Dinshaw K., Sharma V. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation. Indian J Cancer 1990; 27: 143–53, (R3/208)
   PubMedGoogle Scholar
• Hadjieva T., Todorov J., Ivanova K. Some considerations based on preliminary results of twice a day irradiation of nasopharyngeal cancer. Radiobiol Radiother (Berl) 1989; 30: 346–50, (P2/18)
   PubMedGoogle Scholar
• Medini E., Rao Y., Kim T., Jones T., Levitt S. Radiation therapy for advanced head and neck squamous-cell carcinoma using twice-a-day fractionation. Radiology 1980; 134: 531–2, (P2/15)
   PubMed Web of Science ®Google Scholar
• Parsons J. T., Mendenhall W. M., Cassisi N. J., Isaacs J. H., Million R. R. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys 1988; 14: 649–58, (R1/144)
   PubMed Web of Science ®Google Scholar
• Fallai C., Olmi P., Cellai E. Advanced carcinomas of the oropharynx treated with radiotherapy-a comparison of three different fractionation schemes. Am J Otolaryngol 1993; 14: 31–7, (R2/142)
   PubMed Web of Science ®Google Scholar
• Horiot J., LeFur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231–41, (C1/356)
   PubMed Web of Science ®Google Scholar
• Pinto L., Canary P., Araujo C., Bacelar S., Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991; 21: 557–62, (C2/112)
   PubMed Web of Science ®Google Scholar
• Sanchiz F., Mill A., Tomer J., et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1347–50, (C1/859)
   PubMed Web of Science ®Google Scholar
• Cox J., Pajak T, Marcial V., et al. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83–13. Int J Radiat Oncol Biol Phys 1990; 18: 515–21, (C1/237)
   PubMed Web of Science ®Google Scholar
• Cox J. D., Pajak T. F., Marcial V. A., et al. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. Cancer 1992; 69: 2744–8, (C2/233)
   PubMed Web of Science ®Google Scholar
• Marcial V., Pajak T., Chang C., Tupchong L., Stetz J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality. Int J Radiat Oncol Biol Phys 1987; 13: 41–7, (C2/210)
   PubMed Web of Science ®Google Scholar
• Wang C. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Cancer 1989; 63: 2461–7, (R2/60)
   PubMed Web of Science ®Google Scholar
• McGinn C. J., Harari P. M., Fowler J. F., Ford C. N., Pylc C. M., Kinsella T. J. Dose intensification in curative head and neck cancer radiotherapy-linear quadratic analysis and preliminary assessment of clinical results. Int J Radiat Oncol Biol Phys 1993; 27: 363–9, (P2/40)
   PubMed Web of Science ®Google Scholar
• Begg A., Holland I., Van Glabekke M., Bartelink H, Horiot J. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC Cooperative Trial 22851. Sem Radiat Oncol 1992; 2: 22–5, (C2/85)
   Google Scholar
• Awwad H., Khafagy Y., Barsoum M., et al. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation. Radiother Oncol 1992; 25: 261–6, (C2/56)
   PubMed Web of Science ®Google Scholar
• Trotti A., Klotch D., Endicott J., Ridley M., Greenberg H. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1993; 26: 13–21, (P3/32)
   PubMed Web of Science ®Google Scholar
• Kaanders J. H. A., Van Daal W. A. J., Hoogenraad W. J., van der Kogel A. J. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity. Int J Radiat Oncol Biol Phys 1992; 24: 497–503, (P2/58)
   PubMed Web of Science ®Google Scholar
• Wang C., Blitzer P. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55: 2100–4, (R1/321)
   PubMed Web of Science ®Google Scholar
• Wang C., Suit H., Blitzer P. Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phys 1986; 12: 3–7, (R2/106)
   PubMed Web of Science ®Google Scholar
• Olmi P., Cellai E., Chiavacci A., Fallai C. Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequele. Radiother Oncol 1990; 17: 199–207, (R2/161)
   PubMed Web of Science ®Google Scholar
• Ang K., Peters L., Weber R., Maor M., Morrison W., Wendt C, Brown B. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990; 19: 1339–45, (P2/82)
   PubMed Web of Science ®Google Scholar
• Schmidt-Ullrich R., Johnson C., Wazer D., Masko G., Chasin W., Karmody C. Accelerated superfractionated irradiation for advanced carcinoma of the head and neck: concomitant boost technique. Int J Radiat Oncol Biol Phys 1991; 21: 563–8, (R2/94)
   PubMed Web of Science ®Google Scholar
• Harrison L., Pfister D, Fass D., et al. Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 1991; 21: 703–8, (P1/22)
   PubMed Web of Science ®Google Scholar
• Skoczylas J., Bujko K., Hliniak A., Osmólski A. Concomitant boost radiotherapy of supraglottic cancer-preliminary results morbidity. Neoplasma 1992; 39: 119–22, (P3/42)
   PubMed Web of Science ®Google Scholar
• Johnson C. R., Schmidt-Ullrich R. K., Wazer D. E. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. Cancer 1992; 69: 2749–54, (P1/100)
   PubMed Web of Science ®Google Scholar
• van den Bogaert W., van der Schueren E., Horiot J-C, et al. EORTC Cooperative Group of Radiotherapy: Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1986; 12: 587–91, (C2/583)
   PubMedGoogle Scholar
• Paris K. J., Spanos W. J., Lindberg R. D., Jose B., Albrink F. Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies. Int J Radiat Oncol Biol Phys 1993; 25: 657–60, (P2/37)
   PubMed Web of Science ®Google Scholar
• Saunders M., Dische S., Grosch E, Fermont D., Ashford R., Maher E., Makepeace A. Experience with CHART. Int J Radiat Oncol Biol Phys 1991; 21: 871–8, (R1/263)
   PubMed Web of Science ®Google Scholar
• Lindup R. Multiple fractions in the treatment of head and neck cancer. Clin Oncol 1992; 4: 280–3, (P3/58)
   Google Scholar
• Wong C., Van Dyk J., Simpson W. Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol 1991; 20: 3–9, (R3/32)
   PubMed Web of Science ®Google Scholar
• Dische S. Accelerated treatment and radiation myelitis. Radiother Oncol 1991; 20: 1–2, (O2)
   PubMed Web of Science ®Google Scholar
• Crellin R. P., Macmillan C. H., Berridge J. K., Morgan D. A. L. Multiple fractions daily for head and neck cancer: Spinal cord effects and other late results. Clin Oncol 1993; 5: 139–42, (R2/65)
   Google Scholar
• Cox J., Pajak T., Marcial V., Coia L, Mohiuddin M., Fu K., Selim H., Rubin P, Ortiz H. ASTRO plenary: Interfraction interval is a major determinant of late effects with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group protocol 8313. Int J Radiat Oncol Biol Phys 1991; 20: 1191–5, (C1/479)
   PubMed Web of Science ®Google Scholar
• Prades J., Schmitt T., Perron X., Puel G., Martin C. Radiotherapie per operatoire et cancer de la base de langue. Technique indications et resultats preliminaires. Ann Otolaryngol Chir Cervicofac 1989; 106: 561–5, (O2)
   PubMedGoogle Scholar
• Schmitt T., Puel G., Prades J., Barbet N., Perron X., Mere P. Intraoperative radiotherapy (IORT) for locally advanced carcinoma of the base of the tongue Technique-preliminary results. Ann Radiol (Paris) 4; 32: 505–8, (P3/15)
   Google Scholar
• Garrett P., Pugh N., Ross D., Hamaker R., Singer M. Intraoperative radiation therapy for advanced or recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 1987; 13: 785–8, (P2/28)
   PubMed Web of Science ®Google Scholar
• A1-Sarraf M. Chemotherapy strategies in squamous cell carcinoma of the head and neck. Crit Rev Oncol Hematol 1984; 1: 323–55, (L1)
   PubMed Web of Science ®Google Scholar
• Martin M., Hazan A, Vergnes L., et al. Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: A preliminary report. Int J Radiat Oncol Biol Phys 1990; 19: 973–5, (C3/75)
   PubMed Web of Science ®Google Scholar
• Kaasa S., Thorud E., Tausjö J., Wist E., Evensen J., Gundersen S., Höst H. Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma. Eur J Cancer 1991; 27: 576–9, (P2/59)
   PubMed Web of Science ®Google Scholar
• Grégoire V., Beauduin M., Humblet Y., et al. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: A report from the UCL-Oncololgy Group Belgium. J Clin Oncol 1991; 9: 1385–92, (R3/83)
   PubMed Web of Science ®Google Scholar
• Volling P., Staar S., Achterrath W., Müller R-P. Carboplatin plus radiation therapy in head and neck cancer. Semin Oncol 1991; 18(1)(Suppl 2)17–22, (P3/24)
   Google Scholar
• Forastiere A. Chemotherapy of head and neck cancer. Ann of Oncol 1992; 3: 11–4, (L2)
   PubMedGoogle Scholar
• Tennvall J., Albertsson M., Biörklund A., et al. Induction chemotherapy (cisplatin + 5-fluorouracil) and radiotherapy in advanced squamous cell carcinoma of the head and neck. Acta Oncol 1991; 30: 27–32, (P2/58)
   PubMed Web of Science ®Google Scholar
• Klima A., Klippstein T., Bergmann L., Szepesi S., v Ilberg C. Adjuvant chemotherapy in stage III and IV squamous cell carcinoma of the head and neck. J Laryngol Otol 1988; 102: 337–40, (C3/80)
   PubMed Web of Science ®Google Scholar
• Recondo G., Cvitkovic E., Azli N., et al. Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. Cancer 1991; 68: 2109–19, (P2/54)
   PubMed Web of Science ®Google Scholar
• Mazeron J-J, Martin M., Brun B., et al. Induction chemotherapy in head and neck cancer: Results of a phase III trial. Head Neck 1992; 14: 85–91, (C2/116)
   PubMed Web of Science ®Google Scholar
• Calais G., Reynaud-Bougnoux A., Garand G., Beutter P., Le Floch O. Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation-5 year results. Br J Radiol 1990; 63: 340–5, (R2/205)
   PubMed Web of Science ®Google Scholar
• Richard J., Kramar A., Molinari R., et al. Randomised EORTC Head and Neck Cooperative Group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 1991; 27: 821–7, (C2/222)
   PubMed Web of Science ®Google Scholar
• The Department of Veterans Affairs Laryngeal Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685–90, (C1/332)
   PubMed Web of Science ®Google Scholar
• Depondt J., Gehanno P., Martin M., et al. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncol 1993; 50: 23–7, (C2/300)
   Google Scholar
• Karp D., Vaughan C., Carter R., et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report. Am J Clin Oncol 1991; 14: 273–9, (P2/35)
   PubMed Web of Science ®Google Scholar
• Price L. A., Shaw H. J., Hill B. T. Larynx preservation after initial non-cisplatin containing combination chemotherapy plus radiotherapy as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and neck cancer: final analysis after 12 years follow-up. J Laryngol Otol 1993; 107: 211–6, (R2/73)
   PubMed Web of Science ®Google Scholar
• Nikolaou A., Fountzilas G., Kosmidis P., Banis C., Sobolos K., Daniilidis J. Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment. J Laryngol Otol 1991; 105: 930–3, (P2/28)
   PubMed Web of Science ®Google Scholar
• Pfister D., Strong E., Harrison L., et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991; 9: 850–9, (P2/40)
   PubMed Web of Science ®Google Scholar
• Wolf G. T., Fisher S. G. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992; 102: 934–9, (C2/92)
   PubMed Web of Science ®Google Scholar
• Hill B., Price L. The role of adjuvant chemotherapy in the treatment of advanced head and neck cancer. Acta Oncol 1990; 29: 695–703, (L2)
   PubMed Web of Science ®Google Scholar
• Taylor S. Integration of chemotherapy into the combined modality therapy of head and neck squamous cancer. Int J Radiat Oncol Biol Phys 1987; 13: 779–83, (L2)
   PubMed Web of Science ®Google Scholar
• Gupta N., Pointon C., Wilkinson P. A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 1987; 38: 575–81, (C2/313)
   PubMed Web of Science ®Google Scholar
• Bachaud J-M, David J-M, Boussin G., Daly N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 1991; 20: 243–6, (C3/83)
   PubMed Web of Science ®Google Scholar
• Macmillan C., Carrick K., Bradley P., Morgan D. Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck. Br J Radiol 1991; 64: 941–6, (P3/25)
   PubMed Web of Science ®Google Scholar
• Marcial V., Pajak T., Mohiuddin M., et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 1990; 66: 1861–8, (P1/124)
   PubMed Web of Science ®Google Scholar
• Vikram B., Malamud S., Gold J., et al. Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: a feasibility study. Head Neck 1991; 13: 415–9, (P3/19)
   PubMed Web of Science ®Google Scholar
• Hirsch S., Caldarelli D., Hutchinson J., et al. Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer. Laryngoscope 1991; 101: 583–6, (R3/29)
   PubMed Web of Science ®Google Scholar
• Dobrowsky W., Dobrowsky E., Strassl H., Braun O., Gritz-Mann N, Scheiber V. Combined modality treatment of advanced cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 1991; 20: 239–42, (P2/70)
   PubMed Web of Science ®Google Scholar
• Haraf D., Vokes E., Panje W., Weichselbaum R. Survival and analysis of failure following hydroxyurea 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 1991; 14: 419–26, (P3/39)
   PubMed Web of Science ®Google Scholar
• Fietkau R., Iro H., Grabenbauer G., Altendorf-Hofmann A., Sauer R. Simultane Radio-/Chemotherapie mit Cisplatin und 5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther Onkol 1991; 167: 693–700, (P3/47)
   PubMedGoogle Scholar
• Zamboglou H., Pape T., Schnabel R., Wurm R., Bannach B., Furst G., Schmitt G. Kombinierte Radiotherapie mit Cisoder Carboplatin bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther Onkol 1989; 165: 647–65, (R2/111)
   PubMedGoogle Scholar
• Fu K., Phillips T., Silverberg I., et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410–8, (C2/96)
   PubMed Web of Science ®Google Scholar
• Vermund H., Kaalhus O., Winther F., Transjö J, Thorud E., Harang R. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys 1985; 11: 1877–86, (C2/222)
   PubMed Web of Science ®Google Scholar
• Merlano M., Corvo R., Margarino G., et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. Cancer 1991; 67: 915–21, (C2/116)
   PubMed Web of Science ®Google Scholar
• Keane T. J., Cummings B. J., O'Sullivan B., et al. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 1993; 25: 613–8, (C2/212)
   PubMed Web of Science ®Google Scholar
• Salvajoli J. V., Morioka H., Trippe N., Kowalski L. P. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 1992; 249: 211–5, (C3/90)
   PubMed Web of Science ®Google Scholar
• Tupchong L., Brodovsky H., Rose L., Lowry L. Phase I/II study of hyperfractionated chemoradiotherapy (HFRT-CX) for advanced inoperable head and neck carcinoma. Proc Ann Meet Am Soc Clin Oncol 1991; 10: A689, (P3/19)
   Google Scholar
• Crispino S., Personeni A., Taino R., et al. Radiotherapy (RT) and concomitant plus adjunctive cisplatinum (P) and 5-fluorouracil (F) in locally advanced squamous cell carcinoma of the oropharynx. Eur Cancer News 1992; 5: 8, (P3/25)
   Google Scholar
• Merlano M., Vitale V., Rosso R., et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. New Engl J Med 1992; 327: 1115–21, (C2/157)
   PubMed Web of Science ®Google Scholar
• Stell P., Rawson N. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990; 61: 779–87, (M2)
   PubMed Web of Science ®Google Scholar
• Tannock I. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989; 16: 83–101, (L2)
   PubMed Web of Science ®Google Scholar